Neuropathy Treatment in St. Charles, MO

The drive from St. Charles

From St. Charles, St. Peters, O’Fallon or Cottleville, the clinic is about twenty minutes east on I-70 across the Blanchette Bridge to 4477 Woodson Rd, Suite 104, next to Lambert Airport with on-site parking.

Diabetic is a label, not a diagnosis

Diabetic neuropathy is common in this county, but blood sugar is only one of the systems that starve a nerve. Circulation, nutrition including B12, autoimmune activity and toxic exposure all produce the same burning feet, and the treatment differs for each. Start with how glucose damages nerves.

Matching therapy to the driver

Once the dominant driver is established, care is built from vascular therapy, nerve-regrowth signaling, photobiomodulation, neuromodulation and metabolic correction — the range is on advanced neuropathy treatments. The written plan comes in large print, in plain language.

Why measurement precedes prescription

A nerve deprived of blood supply or cooking in unstable glucose will not recover because the pain signal has been dampened. Correcting the terrain is what gives it the chance. Reasoning at the science of nerve terrain rehabilitation.

Two minutes to a first answer

The free Nerve Damage Score — five large-print questions, a plain-language report by email — indicates which drivers are most likely yours. Take it here.

Frequently asked questions

Nearby: St. Peters · Maryland Heights · Bridgeton · Chesterfield

Who we see from St. Charles

St. Charles patients make a longer drive than most, and a distinct group among them arrives after cancer treatment — symptoms that began during chemotherapy and never fully resolved, often dismissed at the time as a temporary side effect that would settle.

Chemotherapy-induced peripheral neuropathy

CIPN is one of the most common lasting effects of successful cancer treatment, and one of the least followed up. Patients are discharged from oncology with the cancer addressed and the neuropathy unmanaged, frequently having been told nothing can be done.

Which agents, and what they do

Platinum compounds, taxanes and vinca alkaloids each damage peripheral nerve by different mechanisms — some targeting the cell body, others the transport along the axon. The pattern and the timing differ accordingly, and platinum-based neuropathy characteristically continues to worsen for months after treatment ends, which patients are rarely warned about.

Why ‘nothing can be done’ is overstated

It is true that no agent reliably reverses established CIPN. It does not follow that nothing helps. Symptom burden, balance, foot protection and the metabolic factors that impair nerve repair are all modifiable, and many patients have coexisting drivers — deficiency, glucose dysregulation, thyroid dysfunction — that were never assessed because the cause was assumed to be settled.

The assessment we run

Full metabolic and nutritional screening, because a treatable second driver on top of CIPN is common and correctable. What CIPN involves and what the options are covers this in more depth.

Balance after cancer treatment

CIPN affects large fibers heavily, which means position sense suffers and falls risk rises. In a population often also managing deconditioning and sometimes bone density loss, that combination carries real consequence, and it is worth measuring rather than assuming.

Getting here from St. Charles County

The clinic is a straightforward run east on I-70 to Woodson Road with parking at the door. For patients still in active follow-up we schedule around oncology appointments where possible, and visits are structured to be fewer and longer rather than frequent and short.

What treatment involves for this group

Where CIPN is the established cause, the plan divides into three parts.

Treating the second driver

Any coexisting deficiency, glucose problem or thyroid dysfunction is corrected. This is where most of the recoverable ground lies, and it is regularly unexamined.

Reducing symptom burden

Topical agents first where possible, and the capsaicin 8% patch for patients wanting to avoid systemic sedation after years of treatment.

Protecting the feet and the balance

Foot inspection, footwear and a balance program, because the falls risk in this group is real and the bone density often is not what it was.

Follow-up after cancer treatment

Patients discharged from oncology often have no clear owner for the neuropathy. Oncology considers it outside their remit once treatment ends, primary care considers it specialist territory, and the patient falls between the two.

What we provide is that ownership: a baseline measurement, a plan for the modifiable contributors, and a scheduled review rather than an open-ended discharge. Where a second driver is found and corrected, some patients improve considerably more than they were told to expect.

Where it is CIPN alone and established, the honest position is that the aim is symptom burden, balance and foot protection rather than reversal. That is still worth doing, and it is more than most people are offered.

Coordinating with your oncology team

Where you remain in active surveillance, we write to your oncologist with what was found and what is planned, so the neuropathy is managed alongside the cancer follow-up rather than in parallel with it. Nothing here substitutes for that surveillance, and we will say plainly when a symptom belongs to them rather than to us.

Visit Regenerve

See the clinic map & directions · Meet Dr. Padda